Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impaired Neutralizing Antibody Response to COVID-19 mRNA Vaccines in Cancer Patients.
Zeng C, Evans JP, Reisinger S, Woyach J, Liscynesky C, Boghdadly ZE, Rubinstein MP, Chakravarthy K, Saif L, Oltz EM, Gumina RJ, Shields PG, Li Z, Liu SL. Zeng C, et al. Among authors: gumina rj. medRxiv [Preprint]. 2021 Oct 21:2021.10.20.21265273. doi: 10.1101/2021.10.20.21265273. medRxiv. 2021. Update in: Cell Biosci. 2021 Nov 21;11(1):197. doi: 10.1186/s13578-021-00713-2 PMID: 34704093 Free PMC article. Updated. Preprint.
Neutralization and Stability of SARS-CoV-2 Omicron Variant.
Zeng C, Evans JP, Qu P, Faraone J, Zheng YM, Carlin C, Bednash JS, Zhou T, Lozanski G, Mallampalli R, Saif LJ, Oltz EM, Mohler P, Xu K, Gumina RJ, Liu SL. Zeng C, et al. Among authors: gumina rj. bioRxiv [Preprint]. 2021 Dec 20:2021.12.16.472934. doi: 10.1101/2021.12.16.472934. bioRxiv. 2021. PMID: 34981053 Free PMC article. Preprint.
Distinct Neutralizing Antibody Escape of SARS-CoV-2 Omicron Subvariants BQ.1, BQ.1.1, BA.4.6, BF.7 and BA.2.75.2.
Qu P, Evans JP, Faraone J, Zheng YM, Carlin C, Anghelina M, Stevens P, Fernandez S, Jones D, Lozanski G, Panchal A, Saif LJ, Oltz EM, Xu K, Gumina RJ, Liu SL. Qu P, et al. Among authors: gumina rj. bioRxiv [Preprint]. 2022 Oct 20:2022.10.19.512891. doi: 10.1101/2022.10.19.512891. bioRxiv. 2022. Update in: Cell Host Microbe. 2023 Jan 11;31(1):9-17.e3. doi: 10.1016/j.chom.2022.11.012 PMID: 36299423 Free PMC article. Updated. Preprint.
Extraordinary Evasion of Neutralizing Antibody Response by Omicron XBB.1.5, CH.1.1 and CA.3.1 Variants.
Qu P, Faraone JN, Evans JP, Zheng YM, Carlin C, Anghelina M, Stevens P, Fernandez S, Jones D, Panchal A, Saif LJ, Oltz EM, Xu K, Gumina RJ, Liu SL. Qu P, et al. Among authors: gumina rj. bioRxiv [Preprint]. 2023 Jan 17:2023.01.16.524244. doi: 10.1101/2023.01.16.524244. bioRxiv. 2023. Update in: Cell Rep. 2023 May 30;42(5):112443. doi: 10.1016/j.celrep.2023.112443 PMID: 36711991 Free PMC article. Updated. Preprint.
Immune Evasion, Infectivity, and Fusogenicity of SARS-CoV-2 Omicron BA.2.86 and FLip Variants.
Qu P, Xu K, Faraone JN, Goodarzi N, Zheng YM, Carlin C, Bednash JS, Horowitz JC, Mallampalli RK, Saif LJ, Oltz EM, Jones D, Gumina RJ, Liu SL. Qu P, et al. Among authors: gumina rj. bioRxiv [Preprint]. 2023 Sep 12:2023.09.11.557206. doi: 10.1101/2023.09.11.557206. bioRxiv. 2023. Update in: Cell. 2024 Feb 1;187(3):585-595.e6. doi: 10.1016/j.cell.2023.12.026 PMID: 37745517 Free PMC article. Updated. Preprint.
Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants.
Qu P, Xu K, Faraone JN, Goodarzi N, Zheng YM, Carlin C, Bednash JS, Horowitz JC, Mallampalli RK, Saif LJ, Oltz EM, Jones D, Gumina RJ, Liu SL. Qu P, et al. Among authors: gumina rj. Cell. 2024 Feb 1;187(3):585-595.e6. doi: 10.1016/j.cell.2023.12.026. Epub 2024 Jan 8. Cell. 2024. PMID: 38194968 Free PMC article.
101 results